However, isolated post-marketing reports and theoretical concerns about altered gut motility warrant careful attention
That being said, its worth noting that GLP-1s may actually be beneficial for IBD patients who are stable, since weight loss can lessen inflammation, which can worsen symptoms of these conditions, Holly Lofton, MD, clinical associate professor of medicine and director of the Weight Management Program at NYU Langone Health, tells SELF
Where and how to inject Wegovy: the best Wegovy injection sites Key highlights Wegovy (semaglutide) is an FDA-approved subcutaneous injection prescribed for chronic weight management in obese and overweight individuals
Yes, they delay progression to diabetes
Exercise: Physical activity lowers blood pressure on its own and helps with weight loss
There are reports of people some of whom are not obese and dont have diabetes using GLP-1 medications, Low Wang said